BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1.16	0.88	1.71	21.03	3.06	0
Short-Term Investments	15.26	10.18	13.04	0	0	0
Cash & Cash Equivalents	16.42	11.07	14.75	21.03	3.06	0
Cash Growth	32.68%	-24.97%	-29.85%	586.11%	184071.27%	-98.58%
Receivables	0.04	0.02	0.02	0.01	0.02	0.03
Other Current Assets	0.32	0.31	0.36	0.44	0.11	0.04
Total Current Assets	16.77	11.39	15.13	21.47	3.19	0.07
Property, Plant & Equipment	0.48	0.51	0.5	0.4	0.5	0.66
Goodwill and Intangibles	0.69	0.71	0.8	0.59	0.66	0.74
Other Long-Term Assets	0.01	0	0	0	0	0
Total Long-Term Assets	1.18	1.22	1.31	0.99	1.16	1.4
Total Assets	17.95	12.61	16.43	22.45	4.35	1.47
Accounts Payable	0.23	0.19	0.17	0.05	0.12	1.95
Current Debt	0.12	0.16	0	0.06	0	7.23
Other Current Liabilities	3.09	2.26	5.81	0.25	0.93	4.53
Total Current Liabilities	3.45	2.61	5.98	0.36	1.04	13.72
Long-Term Debt	0	0	0.16	0.49	4.63	0.52
Total Long-Term Liabilities	0	0	0.16	0.49	4.63	0.52
Total Liabilities	3.45	2.61	6.14	0.86	5.68	14.24
Total Debt	0.12	0.16	0.16	0.55	4.63	7.75
Debt Growth	-	-	-70.58%	-88.10%	-40.23%	86.85%
Retained Earnings	-148.92	-146.7	-136.28	-134.15	-89.84	-78.57
Shareholders' Equity	14.5	10	10.29	21.6	-1.33	-12.78
Net Cash / Debt	16.29	10.9	14.59	20.48	-1.57	-7.75
Net Cash / Debt Growth	33.01%	-25.25%	-28.76%	-	-	-
Net Cash Per Share	2.44	2.58	4.03	17.24	-3.98	-1391.92
Working Capital	13.32	8.78	9.15	21.1	2.14	-13.65
Book Value Per Share	2.17	2.37	2.84	18.18	-3.37	-2294.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).